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2Summary
Picornavirus 2B, a non-structural protein required for effective viral replication, has 
been implicated in cell membrane permeabilization during the late phases of infection. 
Here, we have approached the molecular mechanism of this process by assessing the 
pore-forming activity of an overlapping peptide library that spanned the complete 2B 
sequence. At non-cytopathic concentrations, only the P3 peptide, spanning 2B residues 
35-55, effectively assembled hydrophilic pores that allowed diffusion of low-molecular 
weight solutes across the cell plasma membrane (IC50 ≈ 4x10-7 M) and boundary 
liposome bilayers (starting at peptide-to-lipid mole ratios > 1:104). Circular dichroism 
data were consistent with its capacity to fold as a helix in a membrane-like environment. 
Furthermore, addition of this peptide to a sealed plasma-membrane model, consisting of 
retinal rod outer segments patch-clamped in a whole-cell configuration, induced within 
seconds ion channel activity at concentrations as low as 10-8 M. Thus, we have 
established a "one-helix" 2B version that possesses the intrinsic pore-forming activity 
required to directly and effectively permeabilize the cell plasma membrane. We 
conclude that 2B viroporin can be classified as a genuine pore-forming toxin of viral 
origin, which is intracellularly produced at certain times post-infection.
3Introduction:
Induction of non-selective pores in membranes constitutes an ancestral form of 
defense-offense adopted by a wide variety of organisms 1; 2; 3; 4; 5. Cytolytic pore-
forming proteins and peptides targeting the plasma membrane of animal cells are 
produced by bacteria, vertebrates (as components of their immune systems), sea 
anemones, amoeba and fungi, and are also present in the venom of arthropods and 
snakes 1; 2; 4; 6; 7. Although these cytotoxic polypeptides share little sequence homology, 
they almost invariably assemble into permeating structures that allow passive flux of 
ions and other solutes across membranes 1; 2; 8; 9. To date, no functional homologs of 
viral origin similar to these ancient weapons have been discovered, even though 
enhanced membrane permeability is typically observed during infection of susceptible 
cells by most animal viruses 10. 
Membrane permeabilization, together with morphological alterations induced by 
virus replication such as nuclear modifications, disruption of the cytoskeletal network 11; 
12; 13 and the appearance of cytoplasmic membrane vesicles 14; 15 have been collectively 
referred to as the cytopathic effect. In the case of naked viruses, intracellular 
accumulation of viral particles and/or massive expression of viral products have often 
been causally linked to non-specific membrane damage processes that are postulated to 
enhance permeability, cell lysis and ultimately release of new progeny 16; 17. An 
alternative possibility in which specific, virally encoded products sustain this 
phenomenon was predicted many years ago 18; 19; 20. The results of a variety of 
experiments pointed to the involvement of certain pore-like structures in the process. 
Membrane leakiness observed after the mid-phase of picornavirus infection was non-
specific for ions and small molecules (e.g., nucleotides, sugars, amino acids and 
4inhibitors with a MW below 1,500 daltons), but not for macromolecules 10. Moreover, 
individual expression of distinct viral genes was subsequently found to reproduce this 
process in several cell systems 21; 22; 23; 24; 25; 26; 27; 28; 29. The name "viroporin" was 
proposed on observing that several virus proteins with potential permeabilizing activity 
might share common characteristics 26; 30; 31; 32. 
The picornavirus 2B viroporin has received much attention for several reasons. 
First, picornaviruses provide an example of enhanced membrane permeability during 
the latter phases of the virus cycle 19; 33; 34. Second, individual expression of 2B induces 
plasma membrane permeabilization in mammalian cells, the effect being even stronger 
for 2BC precursor 21; 22; 23; 28; 32; 35; 36. Third, the 2B sequence bears two potential 
transmembrane domains (TMDs), which, although of modest hydrophobicity, might 
allow partitioning into membranes and oligomeric pore assembly 27; 29; 32; 37; 38. Indeed, 
evidence for 2B oligomerization at membrane surfaces has been obtained in culture 
cells and liposomes 35; 37. Finally, a soluble and purified 2B fused to maltose binding 
protein (MBP-2B) induces liposome permeabilization to low-molecular weight solutes 
37. Taken together, this evidence suggests a mechanism of membrane permeabilization 
similar to that of certain cytolytic toxins. 
In the present work, we provide compelling evidence for the intrinsic capacity of 
poliovirus (PV) 2B viroporin to form stable, size-limited, non-selective pores at the cell 
plasma membrane. We have identified within a library that spanned the complete 2B 
sequence a helical peptide that displayed 2B-like permeabilizing activity when added to 
cultured cells in the nM range concentration. Plasma membrane permeabilization was 
limited to low molecular-weight solutes, operated at 4 and 37 ºC, and was inhibited by 
the external addition of impermeable streptavidin when biotinylated peptides were used. 
Direct and irreversible pore-formation on plasma membrane under physiological 
5conditions was finally confirmed by a series of electrophysiological measurements, 
which revealed ion channel activity developing within seconds after applying directly 
the peptide onto a cell recorded in whole-cell configuration. We conclude that 2B 
viroporin constitutes a new class of pore-forming protein that functions during infection 
as an intracellularly delivered toxin. Accordingly, we speculate that viroporin lytic 
domains might represent new potential leads for the development of bioactive peptides, 
and/or serve as targets for the development of antiviral compounds.
Results:
Mapping cell permeabilizing activity with a 2B peptide library
Based on the fact that synthetic peptides representing a single helix may retain 
the capacity of the parental polypeptide sequences to assemble ion channels and pores 
in membranes 39; 40; 41; 42, we synthesized a library of soluble peptides (Table 1), and 
assayed them for their capacity to permeabilize cultured cells (Figure 1). Moreover, 
TMD mimics designed as soluble species have been used for the analysis of the specific 
in-membrane molecular recognition sustaining channel and surface receptor function 43; 
44; 45; 46. Even if P3 bears an amphipathic character at its N-terminus, we found 
empirically that this sequence required at least 3 extra Lys residues to become a water-
soluble species (not shown). Thus, both P3 and P5 peptides spanning 2B most 
hydrophobic regions (Figure 1A) included additional Lys-residues (Table 1) to yield the 
6hydrophobicity of a range of previously described aqueous-soluble TMD sequences 44; 
47. 
The data shown in Figure 1B compare the abilities of the peptides to 
permeabilize cell monolayers. Single expression of 2B from an alphavirus replicon 
induces entry of the translation inhibitor hygromycin B (HB) into BHK-21 cells, a 
process that can be monitored as a reduction in protein synthesis by the culture (right-
hand panel). Similarly, addition of P3 to the culture medium permeabilized cells to HB 
efficiently, whereas the rest of the peptide-library had virtually no effect, as was the 
case for untreated controls (left-hand panel). This trend in the cell monolayer 
permeabilization process induced by 2B peptides was observed even with the highest 
concentration tested (20 M, not shown). 
In our assays, the peptides partitioned from the aqueous medium into the 
membranes of culture cells. In order to estimate the capacity of each peptide to insert 
into the cell plasma membrane under these experimental conditions, their insertion into 
lipid monolayers was measured (Table 1). Estimation of the critical pressure for 
insertion (i.e., the surface pressure at which the sequences were excluded from the lipid 
monolayer, c) indicated that the P3 capacity for insertion correlated with its 
permeabilizing activity. P5, which was unable to effectively permeabilize cells, also had 
a high capacity for insertion into membranes, while P4, comprising the sequence that 
connects P3 and P5, was clearly unable to penetrate at the surface pressures present in 
unstressed natural membranes (c ≥ 30 mN/m). 
Figure 2 displays the circular dichroism (CD) spectra of P3, P4 and P5 in the 
presence and absence of detergent micelles. These sequences behaved in opposing 
ways. P3 exhibited a certain degree of structuring in solution whereas P4 and P5 were 
largely unstructured. This finding suggests that P3 might form oligomers under these 
7conditions. The observation that P3 CD spectra measured at 10 and 100 M 
concentration were similar, together with the fact that C-terminal Trp fluorescence 
increased linearly with increasing concentrations would be consistent with the existence 
of a predominant one-sized P3 oligomer (not shown). 
P3 also adopted a highly -helical conformation in solutions containing sodium 
dodecyl sulfate (SDS), consistent with its further structuring in the membrane-
mimicking detergent micelles 44; 47. By comparison, P4 remained largely unstructured, 
while P5 helicity was modest in the presence of micelles. All the additional 2B peptides 
were unstructured in solution (not shown). Interestingly, amino-terminal P1 acquired 
certain degree of -helical conformation in the presence of SDS micelles, while P2 and 
P6 sequences became structured to a lesser extent (not shown).
Membrane permeabilization induced by 2B-derived P3 peptide in BHK-21 cells and 
liposomes
Together results in Figures 1 and 2 demonstrate that porating activity maps to an 
amphipathic-hydrophobic 2B region (represented by P3), which is connected through a 
soluble sequence (represented by P4) with a second hydrophobic domain potentially 
able to insert into membranes (represented by P5). The data shown in Figures 3-5 
compare in detail the abilities of P3 and P5 to permeabilize cell monolayers and lipid 
vesicles. Figure 3A displays a titration experiment in which concentrations as low as 1 
M of P3 were enough to almost totally permeabilize cell cultures to HB. The dose-
dependent assays actually revealed an apparent IC50 of ca. 400 nM. P5, used as a 
8specific negative control able to insert into membranes, did not significantly 
permeabilize cells at the highest concentrations tested (i.e., 10 M). 
To provide further evidence of the intrinsic capacity of P3 to form similar pores 
in pure lipid bilayers, we analyzed the entry of solutes into large unilamellar vesicles 
(LUV) after exposure to peptide (panel B). Entry of solutes was evaluated by 
calculating the percentage of N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) NBD reduced by 
externally added dithionite. In symmetrically labeled vesicles, this compound reduced 
NBD by approximately 50%, as estimated from the decrease in fluorescence intensity 
(CTL in left-hand panel), indicating specific reduction of the probe residing in the 
external membrane leaflet. We thus took this value to represent a zero level of solute 
entry and assigned complete NBD reduction in detergent-solubilized vesicles the value 
of 100% entry. The data in Figure 3B (right-hand panel) clearly indicate that P3-bearing 
vesicles efficiently allowed the entry of solutes, whereas vesicles loaded with P5 were 
barely permeable to dithionite. P3-induced permeabilization reached its maximum 
extent at peptide-to-lipid mole ratios (Ri-s) below 1:1000. Completion of the process at 
such low peptide doses suggests that permeabilization was not just a result of adding 
massive amounts of peptide to the vesicle membrane.
The results in Figure 4 support that permeabilization in this range of Ri-s 
developed through discrete structures of a limited size. In line with the phenomenon 
observed during the latter phases of PV infection, addition of P3 to cells did not make 
the plasma membrane permeable to the -sarcin (MW: 16000) macromolecule (panel 
A). Assembly of size-limited P3 pores at low membrane loads was confirmed assaying 
the leakage from LUV encapsulating solutes with different MW (panel B). Notably, P3 
permeabilized vesicles to ANTS (MW: 425) at doses that did not induce any significant 
FD-4 (MW: 4000) or FD-10 (MW: 10000) release (Figure 4B, top panel). By 
9comparison, vesicle permeabilization induced at a similar Ri by tetanolysin, a protein 
known to produce membrane lesions which allow the passage of macromolecules across 
membranes48, resulted in the simultaneous release to the medium of ANTS and FD-10 
(slashed lines). Increasing P3 concentration induced some release of FD-4, while FD-10 
was retained in the aqueous lumen of the liposomes (Figure 4B, bottom panel). This 
would be consistent with a maximal size of the P3 pore in the order of 20-25 Å49 under 
these conditions.
Overall, these observations suggest the presence in cell plasma and vesicle 
membranes of stable open aqueous channels with common characteristics (sequence 
specificity, solute size limit and stability). The fact that P3-induced permeabilization 
also occurred at 4ºC, a temperature at which receptor-mediated endocytosis is inhibited, 
reinforced this notion (Figure 5). Moreover, cell membranes remained permeabilized 
after removal of P3 from the medium and when cell cultures were allowed to return to 
normal temperature conditions (37ºC). 
P3 permeabilizing activity is inhibited at plasma membrane
The effects described in the previous Figures 3-5 point to direct insertion into 
the lipid phase of the cell plasma membrane as responsible for the P3-induced 
permeabilization phenomenon. The localization of P3 at the plasma membrane was 
confirmed by confocal microscopy (Figure 6A), using binding of fluorescein-labeled 
streptavidin (Strep-FITC) to biotin attached at the peptide carboxy-terminus for 
detection. Inactive P5 sequence was localized to the same extent at the plasma 
membrane, again suggesting that plasma membrane-association alone was not enough 
to sustain cell permeabilization. The ability of impermeable streptavidin to bind the 
biotinylated peptide was subsequently exploited in order to test whether P3-induced cell 
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permeabilization occurred at the level of the plasma membrane (Figure 6B). Incubation 
of both streptavidin and peptide in solution before addition to culture cells revealed an 
inhibitory effect of streptavidin on P3-induced permeabilization to HB (Protocol "a"). 
Moreover, this inhibitory effect was also observed when P3 was pre-incubated with 
cells to allow its insertion into membrane (Protocol "b"). 
Direct inhibition of biotinylated P3 by streptavidin was confirmed in pure lipid 
vesicles using similar protocols (Figure 6C). Streptavidin addition (indicated by the 
arrows) to the vesicles prior to peptide could inhibit the release of internal aqueous 
contents induced by P3 (panel a). The ongoing permeabilization process could be also 
arrested by adding streptavidin after the peptide (panel b). Thus, the fact that 
recognition of membrane-bound P3 by non-permeant streptavidin inhibited 
permeabilization is consistent with the idea that P3 established permeating pores at the 
surface of cells and liposomes. We surmise that the most likely explanation for the 
inactive streptavidin-peptide conjugate could be that binding of the peptide to 
streptavidin might prevent the creation of an oligomer and hence inhibit pore formation.
Fast and irreversible formation of P3 ion channels after addition to a natural plasma 
membrane
Electrophysiological measurements finally confirmed that P3-induced cell 
permeabilization was occurring through a direct pore-forming mechanism and not 
indirectly by affecting other cellular components (Figure 7). Kinetics of P3 ion channel 
formation was studied in the isolated retinal rod outer segments (OS) of amphibia (see 
Figure 7A). This system was selected because patch-clamped OS allow the detection of 
currents on a natural cell plasma membrane, i.e., under physiological conditions that 
preserve its lipid asymmetry and composition. 
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Frog OS possess just two endogenous conductances: the light sensitive 
channels and the Na+:Ca2+, K+ exchanger 50; 51; 52. If the OS are illuminated, the light 
sensitive channels close; furthermore, the exchanger can be blocked by removing just 
one of the ion species that it transports (Na+, Ca2+ or K+) from both sides of the 
membrane. The exchanger current can be also reduced to negligible amplitudes by 
minimizing the electrochemical gradients of the transported ions. Under these 
conditions, the OS membrane resistance recorded in whole cells (Figure 7A) typically 
exceeded 1 G, allowing the detection of developing currents produced by the added 
peptides with high resolution (1 pA for a bandwidth of at least 1 kHz, Figure 7B).
The kinetics of ion channel formation after P3 and P5 addition was therefore 
tested as follows (Figures 7A and B). With the isolated OS continuously held at a fixed 
voltage (Vh; range: -60 - +60 mV), the membrane resistance (Rm) was measured before 
peptide perfusion. The peptide was then quickly applied (<100 ms) using a fast 
perfusion system (Figure 7A) and Rm was measured again once the current had 
stabilized. The OS were finally returned to the control solution (without the peptide) to 
assess a possible recovery of the current. 
No significant changes in current level or Rm were induced by continuous 
perfusion of P5 (5 out of 5 OS) for up to 100 seconds at concentrations up to 1 M 
(Figure 7B, gray traces).  In these experiments, Vh was varied between –60 and +60 mV 
to rule out the possibility that the lack of ion channel formation was due to an 
inappropriate Vh. For instance, many peptides such as peptaibols permeabilize the 
membrane to ions when the intracellular side is held at a negative voltage 53. In contrast, 
P3 was able to significantly permeabilize the OS plasma membrane to ions when 
applied at concentrations as low as 10 nM (Table 2). Perfusion at 100 nM for a few tens 
of seconds (typically ~40 s) permeabilized the OS plasma membrane to the extent that 
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Rm decreased by three orders of magnitude and became comparable to the access 
resistance in approximately one minute (Ra, Figure 7B, black traces; see also Table 2). 
The increase in plasma membrane permeability to ions induced by the peptide 
can be quantitatively described in this system by kinetic parameters such as the 
"activation delay", defined as the time between peptide application and when a change 
of the current baseline larger than 3 times its average value occurs (indicated by the 
arrow in the inset of Figure 7B), and the current amplitude at steady-state. In the case of 
P3, at a fixed voltage (Vh = -20 mV), the activation delay and the current amplitude 
displayed inverse and direct relationships, respectively, with P3 concentration (Table 2). 
Both parameters were independent of Vh over the range –60 to +60 mV. Accordingly, 
the current to voltage relationship, measured once the current was stable with a voltage 
ramp from –60 to +60 mV (Figure 7C), was linear and similar to that predicted by 
Ohm’s law with a resistance approximately equal to Rm (22 M in the example of 
Figure 7C).
In order to evaluate P3 potency as an ion-channel former, its activity was 
compared to that of the standard -helical pore-forming peptide alamethicin 54, 
measured under exactly the same experimental conditions (Figure 7D). Alamethicin 
addition induces ion channels in membranes through the self-association into rings of 
transmembrane helices 5; 55; 56, which are very efficient at increasing conductance of 
artificial lipid bilayers 57. Thus, the activation delay times for 1 M alamethicin assayed 
in the OS system was in the range of 2 seconds, a value lying in between those obtained 
for 0.1 and 1 M of P3, whereas the current amplitude at steady-state was roughly one 
third of that produced by 0.1 M of P3. Thus, in electrophysiological measurements of 
natural OS plasma membranes, P3 would be at least 10 times more potent than 
alamethicin as an ion-channel former. 
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Discussion
Membrane-porating proteins constitute an ancient element in defense-offense 
systems evolved by organisms of diverse origin 1; 5. The results of our work provide the 
first experimental evidence that a non-structural viral protein from a naked virus is 
endowed with a functional pore-forming domain. This isolated PV 2B domain added to 
cell monolayers reproduces the permeabilization phenomenon observed after the mid-
phase of cell infection by PV, i.e., diffusion of small solutes but not macromolecules 
across the membrane without any evident morphological degeneration accompanying 
the latter phases of the cytopathic effect. Our peptide-based approach also allowed 
specific mapping of this 2B activity to the partially amphipathic P3 sequence (Figure 1). 
P5, representing a second transmembrane domain, also inserted into lipid monolayers 
and was located at the cell plasma membrane, but was devoid of the cell-permeabilizing 
activity of P3.
Our previous mutagenesis studies in the context of 2B expressed in cells 
indicated that truncation of 30 amino acids at the amino-terminus severely impaired 
plasma membrane permeabilization by the protein 21. This mutant was intracellularly 
synthesized by the translational machinery and subsequently transported to the site of 
permeabilization, while peptides in the present study were supplied exogenously and, 
therefore, had direct access to the plasma membrane. Only P3 was endowed with the 
capacity of permeabilizing the plasma membrane (panel B in Figure 1). Thus, from the 
combination of both approaches we propose now that deletion of the first 30 residues of 
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2B may affect proper in-membrane folding and/or its trafficking along the vesicular 
system. Moreover, P1, P2 and P6 peptides became structured to some degree in SDS 
micelles and inserted into lipid monolayers at lateral pressures slightly above 30 mN/m 
(Table 1), suggesting that the 2B sequences represented by these peptides might also 
play supportive functional roles in permeabilization, for instance as structural partners 
that ensure membrane insertion or regulate the pore-opening process.
The potency of the P3 sequence (active in the nM range) and the observation 
that the process is efficient in the absence of active transport (Figures 3 and 5) support 
the formation of channel-forming pores directly at the plasma membrane as the likely 
mechanism for P3-induced cell permeabilization. Furthermore, these pores are discrete 
and stable structures (i.e., they remain opened once they assemble and show a limiting 
size for the permeating solute) both in cells and lipid vesicles (Figures 3 and 4). In 
support of this view, biotinylated-P3 itself localizes at the plasma membrane and its 
action might be inhibited by external addition of streptavidin (Figure 6A) which, 
together with the fact that the peptide pores could be inhibited also in pure lipid vesicles 
(Figure 6B), is again indicative that cell permeabilization is mediated by P3 pores 
established directly in the lipid phase of the plasma membrane.
In the case of antimicrobial peptides it has been established a correlation 
between biological activity and binding and disrupting of model membranes58 . In this 
regard, P3's behavior, namely, structuring in solution and capacity to permeabilize 
animal cell membranes and zwitterionic vesicles, parallels that of certain natural 
membranolytic peptides, such as cecropin-like human LL-3759; 60, and synthetic species 
covalently linked to pre-form bundles61. Two main mechanisms have been proposed to 
explain membrane disruption by antimicrobial peptides5; 62: discrete pores (channel-
forming model)  or detergent-like action (carpet model). Existence of a P3 discrete pore 
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(either barrel-stave54 or toroidal63 type) is supported by its capacity to permeabilize 
electrically neutral bilayers to low-molecular weight solutes at doses ranging from 
1:10.000 to 1:1000 peptide-to-lipid mole ratios. In comparison, cationic peptides 
permeabilizing vesicles via a detergent-like "carpet" mechanism require negatively 
charged phospholipids and substantially higher peptide-to-lipid mole ratios5; 62; 64. 
The P3 pore hypothesis received conclusive support from electrophysiological 
measurements carried out on the frog OS model (Figure 7). This approach allowed the 
ion channel activity of P3 to be measured in a natural plasma membrane, i.e., under 
experimental conditions comparable to those in cell permeability assays. The measured 
activation delay times (arrow in the inset of Figure 7B) were in the order of few 
seconds, supporting that the assembly of P3 pores occurs directly at the plasma 
membrane.  Moreover, in accordance with the results of experiments in cell and lipid 
vesicles that can sustain stable open structures, P3 irreversibly induced membrane 
currents when applied at low doses to OS. In comparison with alamethicin, a known 
amphipathic helical peptide that efficiently establishes "barrel-stave" channels in 
membranes 5; 55; 57, P3 was approximately 10 times more potent at increasing OS 
membrane conductance. 
The model in Figure 8 suggests possible structural correlations between P3 and 
2B pores formed in the cell plasma membrane. Overall hydrophobic P3 sequence may 
attain in the external solution a periodic structure which exposes positively charged Lys 
residues in one of its sides (a), and subsequently self-assemble to shield the 
hydrophobic surfaces (b). In the resulting oligomeric P3 form (c) the amino-terminal 
end would be hydrophilic (pale grey surface), while the carboxy terminus would be 
overall hydrophobic (black). This degree of amphipathicity allows both, enough 
solubility and potential for association with the uncharged external plasma membrane 
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monolayer through hydrophobic interactions. In the membrane-inserted state the 
charged residues reorient towards the lumen of an aqueous channel (d). In the 2BC 
precursor there exists the possibility of shielding hydrophobic sequences into the 
globular structure (e). Electrostatic interactions are probably important for its 
association with cell membrane monolayers topologically equivalent to the negatively 
charged internal monolayer of the plasma membrane. Several monomers are probably 
recruited at the membrane surface to establish an aqueous channel (f). In the latter 
oligomeric structure P3-P5 sequences would combine in each monomer to form a 
hairpin "-loop-" motif so that both the N- and the C-terminal ends of the polypeptide 
remain at the same side of the membrane. In such a model the amphipathic P3 helix 
would serve to establish the interface between the lumen of the aqueous pore and the 
hydrophobic milieu of the membrane, adopting a topology reminiscent to that in the 
pore formed by the synthetic peptide (compare f and d). 
However we caution that at this point we cannot rule out the existence of P3 
topologies, different to membrane-spanning helices, which might be also lytic. In 
addition, the channel-forming model presented in Figure 8 does not discriminate 
between only-protein channels (barrel stave pore40; 62) or pores that are also participated 
by membrane phospholipids (toroidal pores56 62; 63). In the former case, ca. 10 
monomers would participate in forming a pore with a diameter of 20-25 Å49 (not shown 
in the cartoon). Finally, as discussed above, it is likely that other regions of the 2B 
stretch, including amino-terminal sequences and P5, also participate in the assembly of 
pores by the complete 2BC protein expressed during infection.
Taken together, our data demonstrate that 2B contains a structural motif that can 
by itself form permeating pores. Its efficacy, together with the observation that this 
region can cause direct permeabilization of the cell plasma membrane, suggests the 
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existence of a selective pressure for the membrane-porating function. Pore-forming 
proteins are secreted by cytotoxic T lymphocytes and natural killer cells as a key 
component of a defensive response 65. Perforin, related complement subunits and 
smaller polypeptides such as granulysin or NK-lysin are all released in close proximity 
to the target cell plasma membrane where they establish transmembrane pores 1; 66; 67; 68; 
69. Several short peptides derived from the parental sequence as well as proteolytic 
fragments are able to reproduce perforin lytic activity, providing evidence that distinct 
core transmembrane domains are responsible for pore-formation 42; 70. Thus, it may be 
that similar pore-forming motifs were co-opted during the course of evolution of certain 
viruses in order to induce cell death under conditions of cytopathic infection.
The precise function of 2B during the PV infectious cycle has yet to be 
elucidated. Overexpressed 2B species accumulate in the endoplasmic reticulum and the 
Golgi apparatus, interfere with transport of glycoproteins to the cell surface, induce 
internal membrane restructuring and increase the levels of cytoplasmic calcium and 
other ions 21; 22; 23; 28; 35; 71. Researchers have proposed that many if not all of these 
effects are a consequence of the membrane permeabilizing capacity of these species 36. 
Thus, 2B-generated solute imbalance across cellular endomembranes might 
compromise organelle function, thereby creating suitable conditions for productive viral 
replication. Our studies support this possibility, while contributing to the knowledge of 
the 2B non-selective pore architecture.
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Concluding remarks
Non-structural enterovirus 2B has been postulated as an example of the 
viroporin family. These virally encoded proteins are postulated to compromise cell 
membrane permeability barriers 30. The existence of a 2B domain optimized for 
membrane-porating function would support the proposal that viroporins represent a new 
class of intracellular toxins. In addition, 2B-derived P3 encompasses a one-helix 
miniprotein with a high pore-forming potency. Hence, its activity in lipid vesicles could 
be used as a surrogate measure in screening for compounds that abrogate this activity. It 
was previously postulated that interfering with 2B viroporin activity might block viral 
replication as well as virus release 28; 35. The present study provides the necessary 
framework to verify that hypothesis. A growing number of viruses that encode viroporin 
sequences have been described 30. It will be of great interest to explore viroporins as a 
source of peptide-based structures to develop new bioactive compounds. 
Materials and Methods
Materials
The poliovirus 2B-derived P1-P6 peptides displayed in Table 1 were produced by solid-
phase synthesis using Fmoc chemistry as C-terminal carboxamides and purified by 
HPLC. Phosphatidylcholine (PC) and N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) 
phosphatidylethanolamine (N-NBD-PE) were purchased from Avanti Polar Lipids 
(Birmingham, AL, USA). Fluorescein-conjugated streptavidin (streptavidin-FITC) and 
dextrans (FD-10 and FD-4), tetanolysin and alamethicin were supplied by Sigma (St. 
Louis, MO, USA). The 8-aminonaphtalene-1,3,6-trisulfonic acid sodium salt (ANTS) 
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and p-xylenebis(pyridinium)bromide (DPX) were obtained from Molecular Probes 
(Junction City, OR, USA). All other reagents were of analytical grade.
Circular Dichroism
CD measurements were carried out on a thermally-controlled Jasco J-810 circular 
dichroism spectropolarimeter calibrated routinely with (1S)-(+)-10-camphorsulfonic 
acid, ammonium salt. Peptide stock samples consisted of lyophilized material dissolved 
in 2 mM Hepes (pH, 7.4) at 0.03 mM. Spectra were measured in a 1 mm path-length 
quartz cell that was initially equilibrated at 25 ºC. Data were taken with a 1 nm band-
width at a scan rate of 20 nm/min, and the results of 5 scans were averaged.
Cell assays
Baby hamster kidney (BHK-21) cells were grown at 37 ºC in Dulbecco´s modified Eagle 
medium (DMEM) supplemented with 5% fetal calf serum (FCS) and non-essential 
amino acids. Peptide-induced membrane permeabilization was achieved by incubating 
BHK-21 cells with the peptides in FCS-free DMEM. Cells were subsequently treated 
with 1 mM HB or 10µg/ml -sarcin for 20 min at 37 ºC. Proteins were then radiolabeled 
for 40 min with 10µCi of [35S]Met-Cys as previously described 72. Protein synthesis was 
analyzed by SDS-PAGE and fluorography and quantified by densitometric scanning, 
using a GS-710 calibrated Imaging Densitometer (Bio-Rad). To establish the localization 
of biotinylated P3 and P5 peptides, BHK-21 cells seeded on glass cover slips were 
incubated with 1 µM P3 or 1 µM P5 for 1 hour at 37 ºC, and fixed with 4% 
paraformaldehyde. Cells were incubated with streptavidin-FITC at a dilution of 1:300 for 
45 minutes at room temperature. Finally, the samples were mounted using 
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mowiol/DABCO (Calbiochem) and analyzed in a Radiance 2000 (Bio-Rad/Zeiss) 
confocal laser scanning microscope.
Lipid monolayer assays
For the monolayer penetration assays, surface pressure was determined in a fixed-area 
circular trough (Trough S system, Kibron, Helsinki) measuring 2 cm in diameter and 
with a volume of 1 ml. The aqueous phase consisted of 1 ml of 5 mM Hepes, 100 mM 
NaCl (pH 7.4). Lipids, dissolved in chloroform, were spread over the surface and the 
desired initial surface pressure (0) was attained by changing the amount of lipid applied 
to the air-water interface. Peptides were injected into the subphase with a Hamilton 
microsyringe. At the concentrations used, the peptides alone induced a negligible 
increase in surface pressure at the air-water interface. 
Lipid vesicle assays
Large unilamellar vesicles (LUV) of phosphatidylcholine were prepared according to the 
extrusion method in 5 mM Hepes, 100 mM NaCl (pH 7.4). Vesicle permeabilization was 
assayed by monitoring the release to the medium of encapsulated fluorescent ANTS 
(ANTS/DPX assay 73) or FITC-dextran probes, as previously described 74. In a 
complementary assay, permeabilization was also assessed by monitoring the entry of 
dithionite into vesicles according to the method described by McIntyre and Sleight 75, 
with the modifications introduced by Agirre et al. 37. 
21
Ion Channel activity
Rod outer segments (OS) were mechanically isolated from the retina of dark adapted
Rana esculenta individuals as described by Rispoli et al. 51. OS were recorded using the 
whole-cell configuration of the patch-clamp technique under visual control (Fig. 7A) at 
room temperature (20-22 °C), employing Axopatch 200B (Molecular Devices, 
Sunnyvale, CA, USA). The Ringer had the following composition (in mM): 115 NaCl, 3 
KCl, 10 HEPES, 0.6 MgCl2, 0.6 MgSO4, 1.5 CaCl2, 10 glucose (Osmolality 260 
mOsm/Kg, buffered to pH=7.6; all chemicals were purchased from Sigma Chemical 
Co.). The peak amplitude of the current transient elicited by -5 mV pulses (delivered at 
10 Hz) was used to measure access resistance (Ra), whereas the current amplitude 
elicited by a -10 mV pulse during cell-attached and whole-cell recording was used to
measure seal resistance and membrane resistance (Rm), respectively.
After obtaining the whole cell recording, the cell was aligned in front of a multibarreled 
perfusion pipette that could be moved on a horizontal plane (Fig. 7A). Peptides were 
applied and removed in less than 100 ms by switching the OS back and forth from a 
stream of control perfusion solution (composition, in mM: 130 K+, 1 Ca2+ and 10 
HEPES; Osmolality 260 mOsm/Kg, buffered to pH=7.6) to a stream containing the 
peptide (dissolved in the same perfusion solution). Patch pipettes were filled with the 
same perfusion solution to ensure the current was only driven by the holding voltage 
(Vh). Every perfusion parameter of this computer controlled microperfusion system 
(developed in collaboration with De Angelis s.r.l., Genova, Italy) can be easily 
controlled by a user-friendly computer interface; minimal amounts of peptide solution 
(<500 l) were required to perform peptide applications lasting more than half an hour 
(typical perfusion speed: 15 l/min).
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Recordings were filtered at 2 kHz via an eight-pole Butterworth filter (VBF/8 Kemo, 
Beckenham, UK), sampled on-line at 5 kHz by a Digidata 1322A connected to the SCSI 
port of a Pentium computer running the pClamp 9.0 software package (Molecular 
Devices, Sunnyvale, CA, USA). Figures and statistics were performed using SigmaPlot 
(Jandel Scientific, Sam Rafael, CA). The values presented in the text and figures are 
given as means±SEM.
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Figure legends
Figure 1: Non-structural Poliovirus 2B amino-acid sequence and analysis of 
membrane-permeabilizing activity in a peptide library. A) Direct translation of 
poliovirus positive RNA gives rise to a polyprotein precursor, which is subsequently 
processed through proteolysis to produce 3 protein intermediates. 2B is one of the 3 non-
structural regulatory products that originate from further processing of the second 
intermediate (Top). The hydropathy plots above 2B amino acid sequence correspond to 
mean hydrophobicity calculated using the Wimley-White octanol-water (O-W) 
partitioning scale for a sliding window of 11 amino acids and the moment in the -
helical conformation (black and red-dotted traces, respectively). The blue plot displays 
the permeabilizing capacities of the 2B-derived peptides (Table 1). Values plotted for the 
center amino acid in each sequence correspond to levels of cell permeabilization (see 
below) induced by the peptides assayed at a concentration of 1 M (means ± S.D., n = 
3). B) Cell membrane permeabilization assay based on the reduction in protein synthesis 
induced by the externally added translation inhibitor hygromycin B (HB). Left: Cells 
were incubated with 2B P1-P5 peptides for 1 h before HB addition and then with 
[35S]Met/Cys for 40 min. Only P3-treated cells became permeable to the antibiotic. 
Untreated cells were not permeable to the antibiotic, and peptide addition per se did not 
affect protein biosynthesis. Right: control showing the membrane permeabilization 
induced by the complete 2B protein expressed from "repC+2B" Sindbis virus (SV) 
replicon 76. Most cells were efficiently transfected and so only expression of the SV 
capsid protein (C) and 2B is detected. C expression does not affect membrane 
permeability as described previously 76. 
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Figure 2: Structure of synthetic peptides derived from the 2B hydrophobic region.
CD spectra of P3, P4 and P5 peptides in buffer (dotted lines), and buffer containing 10 
or 50 mM SDS (slashed and continuous lines, respectively). 
Figure 3: Permeabilization of BHK-21 cells and lipid vesicles by P3 and P5 
peptides. A) Entry of solutes into BHK-21 cells. Left panel: Cells were incubated for 1 
hour with 0.5-20 M of P3 and assayed for HB entry as reflected by the inhibition of 
protein synthesis (one representative experiment is shown). Right panel: Quantitation of 
the previous effect. P3-induced HB entry (circles and continuous line) was compared to 
that induced by P5 (squares and dotted line) (mean ± S.D., n = 3). B) Entry of solutes 
into peptide-permeabilized PC vesicles (dithionite assay). Left panel: NBD reduction by 
dithionite. CTL: PC:NBD-PE vesicles treated with dithionite (added at time = 30 s, 
indicated by the arrow); P3 and P5: PC:NBD-PE vesicles preincubated with the 
respective peptides at 1:500 peptide-to-lipid ratio for 30 min, and then treated with 
dithionite. Right panel: dithionite entry into PC vesicles (50 M) pre-loaded with P3 
(circles and continuous line) or P5 (squares and dotted line) at different peptide:lipid 
molar ratios (Ri). Means ± S.D. of 3 independent experiments are represented.
Figure 4: P3-induced permeabilization to solutes of different sizes. A) Cell 
membrane permeabilization to protein synthesis inhibitor -sarcin (MW: 16000). 
Positive control for -sarcin entry consisted in BHK-21 cells infected with SV at a 
multiplicity of infection of 10 or 100 pfu/cell as indicated. Cells became permeable to 
this protein during viral entry 72, but not after P3 addition. B) P3-induced leakage of 
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solutes of different sizes encapsulated into PC vesicles. Top panel: Kinetic traces of 
release of ANTS (MW: 425), FD-4 (MW: 4000), and FD-10 (MW: 10000) were 
obtained at a 1:5000 P3:phospholipid molar ratio and 50 M lipid (continuous lines). 
The arrow indicates the peptide addition time. Slashed lines correspond to tetanolysin 
added to PC:Chol (1:1) vesicles at the same Ri. This protein is reported to establish 
pores which allow passage of macromolecules across membranes48, and therefore 
induced simultaneous release of ANTS and FD-10 from liposomes. Bottom panel:
Extent of P3-induced release of ANTS (circles and continuous trace), FD-4 (squares and 
slashed traces), and FD-10 (triangles and dotted trace) as a function of Ri.
Figure 5: Permeabilization by P3 at low temperature conditions. Cells preincubated 
at 4 ºC were treated (or not) with 5 M P3 for 30 min. HB entry was then tested or, 
alternatively, P3 peptide was removed and the cells were incubated for 90 min at 37 ºC 
in fresh medium. The numbers below each lane represent the percentages of protein 
synthesis of HB-treated cells compared with those corresponding to untreated cells (one 
representative experiment).
Figure 6: Localization and inhibition of P3 at the cell surface. A) Binding of 2B-
derived peptides to BHK-21 cell surface. Cells were either treated with 1 M 
biotinylated P3 or P5 for 1 hour, or left untreated. After fixation, cells were labeled with 
streptavidin-FITC (Strep-FITC) and analyzed in a confocal microscope. B) Inhibition of 
P3-induced cell permeabilization by streptavidin. Two protocols were followed: a) 
biotinylated P3 and streptavidin were pre-mixed and incubated for 15 min at 37 ºC 
before addition to the culture cells; and b) cells were pre-treated with biotinylated P3 for 
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15 min to allow its insertion into membranes (see Figure 5C) and then streptavidin was 
added. Cells were incubated for 1 hour with streptavidin:biotinylated P3 mixtures 
before being subjected to HB treatment.  C) Inhibition of biotinylated P3-induced PC 
LUV permeabilization (ANTS leakage) by incubation with 0.1 M streptavidin (red 
traces), added before ("a" panel) or after ("b" panel) the onset of the process (addition 
times indicated by the arrows). The controls in the absence of streptavidin (black traces) 
were measured at 1:1000 peptide:lipid mole ratio and 50 M lipid.
Figure 7: Membrane conductance changes induced by 2B-derived P3 and P5 
peptides on frog rod outer segments. A) Isolated rod outer segment (OS) recorded in 
whole-cell mode aligned in front of the multibarreled perfusion pipette. (+) and (-) 
arrows denote perfusion flows containing and not containing the peptide, respectively. 
The micrograph on the right shows the same cell at higher magnification. B) Kinetics of 
OS membrane permeabilization induced by P3 and P5. Black trace: current recorded 
during a 75-second continuous perfusion of 100 nM P3 (Vh=-20 mV throughout the 
recording); Gray trace: another OS recorded under the same conditions but perfused 
with 1 M P5. The timing of peptide application is indicated by the line above the 
recordings. Inset: same traces as above, but smoothed to accurately measure the 
activation delay (indicated by the arrow, 4.8 s), and the steady-state amplitude (1.1 nA); 
see text. Rm before peptide application was measured from the current amplitude at –20 
mV (-9.5 pA, Rm= 2.1 G, black trace; -27.0 pA, Rm=0.8 G, gray trace; average: 
1.8±0.9 G, n=7). The Rm following peptide application was measured once the current 
attained steady state by using short (0.74 s) and small (-10 mV) voltage pulses 
(indicated by the asterisk on the gray trace) superimposed on Vh. At steady state, Rm (22 
M) became comparable to Ra (12 M) after P3 application, whereas it did not change 
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significantly after perfusion of 1 M P5. C) Current to voltage relationship measured 
at the steady state with a voltage ramp from –60 to +60 mV (slope: 0.244 mV/ms; Vh=-
20 mV). D) Comparison of delay times and current amplitudes induced by 0.1 M P3 
(black bars), 1 M alamethicin (red bars) and 1 M P3 (blue bar).
Figure 8: Models for pores formed in cells by synthetic P3 and expressed 2BC (on top 
of and underneath the plasma membrane plane, respectively). In 2BC, the grey ellipsoid 
denotes the globular 2C domain, while the grey cylinder would correspond to the 
sequence represented by P5. Membrane gaps exposing phospholipid acyl chains within 
pores are shown for better appreciation of P3 sequence topology, and would be covered 
either with protein residues (barrel-stave40; 62) or phospholipid polar head groups 
(toroidal pore62; 63; 77). See text for details.
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Table 1: Designation of 2B peptides and their insertion capacities in a membrane 
environment.
Peptide Sequence c(mN/m)1
P1 1GITNYIESLGAAFGSGFTQQIS22 33.2
P2 23DKITELTNMVTSTITEKLLKNLIK46 32.9
P3 K-35TITEKLLKNLIKIISSLVIIT55-WKK 44.1
P4 46KIISSLVIITRNYEDTTTVLAT67 <25
P5 KKK-
59EDTTTVLATLALLGCDASPWQWLR82
37.9
P6 74DASPWQWLRKKACDVLEIPYVIKQ97 32.6
1: Capacities for penetration into membranes. Critical surface pressures for insertion 
into a PC monolayer are given.
Table
Table 2: Parameters obtained from the kinetics of P3-induced OS membrane 
conductance increase at different concentrations.
[P3] nM Delay (s)
Amplitude 
(nA)
Rm before
(G
Rm after
(M
Ra
(M
33 (n=3)1 9.9±2.6 0.22±0.08 1.3±0.3 110±40 18±7
100 (n=5) 5.2±0.7 1.0±0.3 2.0±0.8 29±14 17±8
1000 (n=3) 0.5±0.2 nd2 1.2±0.5 ndb 18±8
1: "n" indicates average number of OS
2: at this P3 concentration Rm became smaller than Ra. Rm could not be measured and 
the steady state amplitude was meaningless.
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